Important Safety Information

Do not use if you have had an allergic reaction to LEQVIO (inclisiran) or any of its ingredients.&nbsp;&nbsp; The most common side effects of LEQVIO were: injection site reaction (including pain, redness, and rash), joint pain, and chest cold. These are not all the possible side effects of LEQVIO. Ask your health care provider for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit&nbsp;<a href="https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program" target="_blank" title="www.fda.gov/medwatch">www.fda.gov/medwatch</a>, or call <a href="tel:1-800-FDA-1088">1-800-FDA-1088</a>.&nbsp;

What is LEQVIO? LEQVIO is an injectable prescription medicine used along with diet and exercise to reduce low-density lipoprotein (LDL-C) or “bad” cholesterol in adults with high blood cholesterol levels called hypercholesterolemia (including a type of high cholesterol called heterozygous familial hypercholesterolemia [HeFH]).Please see LEQVIO full <a href="https://www.novartis.com/us-en/sites/novartis_us/files/leqvio.pdf" target="_blank">Prescribing Information</a>.

Indication

Do not use if you have had an allergic reaction to LEQVIO (inclisiran) or any of its ingredients.&nbsp; The most common side effects of LEQVIO were: injection site reaction (including pain, redness, and rash), joint pain, and chest cold. These are not all the possible side effects of LEQVIO. Ask your health care provider for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit&nbsp;<a href="https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program" target="_blank" title="www.fda.gov/medwatch">www.fda.gov/medwatch</a>, or call <a href="tel:1-800-FDA-1088">1-800-FDA-1088</a>.

Not to worry. You can head over to our homepage or check out some of our content.

We're sorry - you do not have access.

The URL may have been incorrectly typed or the page may have been moved, deleted, or incorporated into another part of the website.

The webpage you are looking for is unavailable.

We're sorry - it looks like there is an issue

neutral_0

You are about to leave a Novartis site and continue to an external website independently operated and not managed by Novartis Pharmaceuticals Corporation. 

Coming Soon